Mackenzie Financial Corp Ardelyx, Inc. Transaction History
Mackenzie Financial Corp
- $77.1 Billion
- Q3 2025
A detailed history of Mackenzie Financial Corp transactions in Ardelyx, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 176,835 shares of ARDX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,835
Previous 220,880
19.94%
Holding current value
$1.04 Million
Previous $865,000
12.83%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARDX
# of Institutions
245Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...